Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
29
NCT00006383
Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 30, 2000
Completion: Aug 31, 2009
NCT00038207
Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies
Role: Collaborator
Completion: Sep 30, 2005